Literature DB >> 34024733

Complicated urinary tract infections with diabetes mellitus.

Jun Kamei1, Shingo Yamamoto2.   

Abstract

Patients with diabetes mellitus (DM) sometimes exhibited impaired immune function and aggravated infectious diseases. Urinary tract infection (UTI) is one of the major complications of DM. A systematic literature search was performed in PubMed and Cochrane Library using the following keywords: diabetes mellitus, urinary tract infection, asymptomatic bacteriuria, emphysematous pyelonephritis, emphysematous cystitis, renal papillary necrosis, and sodium-glucose co-transporter 2 (SGLT2) inhibitors. The treatment of UTI in DM patients is not different from that in non-DM patients, and asymptomatic bacteriuria should not be screened or treated. Emphysematous pyelonephritis is a life-threatening renal infection with gas in the renal parenchyma or perirenal space, and 95% of affected patients had DM. Abdominal computed tomography is useful for diagnosis and determining treatment strategies. Medical management and percutaneous drainage are standard initial treatment, and subsequent nephrectomy for non-responders is considered. Nephrectomy, as an initial treatment, should be limited to a selected group of patients with severe conditions. In contrast, antibiotics, glycemic control, and bladder drainage are adequate treatment for most cases of emphysematous cystitis. SGLT2 inhibitors significantly increased the incidence of genital tract infection, but not that of UTI, pyelonephritis, or urosepsis. Here, we present cumulative evidence about etiology and management for complicated UTI with DM, but there was little information about racial differences and further evidence focusing on Asian population will be needed.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Asymptomatic bacteriuria; Diabetes mellitus; Emphysematous cystitis; Emphysematous pyelonephritis; Sodium-glucose co-transporter 2 inhibitor; Urinary tract infection

Mesh:

Year:  2021        PMID: 34024733     DOI: 10.1016/j.jiac.2021.05.012

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study.

Authors:  Riccardo Bartoletti; Francesco Claps; Gabriele Tulone; Alessandro Perotti; Alessandro Zucchi; Niccolò Riccardi; Vincenzo Ficarra; Cosimo De Nunzio; Andrea Tubaro; Alchiede Simonato
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

2.  Emphysematous cystitis and pyelonephritis leading to a diagnosis of type 2 diabetes in an older patient.

Authors:  Emilie Gaud-Luethi; Max Scheffler; Aline Mendes
Journal:  Geriatr Gerontol Int       Date:  2021-11-07       Impact factor: 3.387

Review 3.  An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.

Authors:  Teresa Salvatore; Raffaele Galiero; Alfredo Caturano; Luca Rinaldi; Anna Di Martino; Gaetana Albanese; Jessica Di Salvo; Raffaella Epifani; Raffaele Marfella; Giovanni Docimo; Miriam Lettieri; Celestino Sardu; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.